Knowledge on rare diseases and orphan drugs
COVID-19 & Rare diseases
Rare Diseases Resources for Refugees/Displaced Persons
Search for a rare disease
Familial or sporadic hemiplegic migraine
A rare variety of migraine with aura characterized by the presence of a motor weakness during the aura. There are two main forms depending on the familial history: patients with at least one first- or second-degree relative who has aura including motor weakness have familial hemiplegic migraine (FHM); patients without such familial history have sporadic hemiplegic migraine (SHM).
ORPHA:569
The prevalence of hemiplegic migraine (HM) is one in 10,000, with FHM and SHM being equally frequent.
Typical HM attacks are characterised by motor weakness that is always associated with other aura symptoms, the most frequent being sensory, visual and speech disorders. In addition, basilar-type symptoms occur in up to 70% of patients. Severe attacks may occur in both FHM and SHM with prolonged hemiplegia, confusion, coma, fever and seizures. The clinical spectrum also includes permanent cerebellar signs (nystagmus, ataxia, dysarthria) and less frequently various types of seizures and intellectual deficit.
The three causative genes identified so far encode ion-transporters (CACNA1A, ATP1A2 and SCNA1). Molecular diagnosis is now possible through screening of these three genes.
FHM is transmitted in an autosomal dominant manner.
Treatment involves the same approaches used for other varieties of migraine with aura, with the exception that triptans are contraindicated in FHM/SHM. Based on new pathophysiological insights, preventive treatments using various antiepileptic agents seem promising.
Prognosis is usually good.
Last update: April 2008 - Expert reviewer(s): Dr Anne DUCROS
: produced/endorsed by ERN(s)
: produced/endorsed by FSMR(s)
Guidelines
Disease review articles
Further information on this disease
Patient-centred resources for this disease
Research activities on this disease
Newborn screening